Announced
Completed
Financials
Sources
Tags
United Kingdom
health care
Friendly
Public
Pharmaceuticals
Venture Capital
Private Equity
Single Bidder
biotechnology
pharma
Acquisition
Completed
Minority
Domestic
Synopsis
Durable Capital Partners, a private equity firm, completed the 110m investment in Abcam, a UK biotechnology company. "Today's equity raise provides greater flexibility to invest in the long term growth of our business to support our customers and capture additional market share through organic and inorganic initiatives," Alan Hirzel, Abcam Chief Executive.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.